Valuation: Epigral Limited

Market Cap 47.39B 496M 428M 402M 366M 688M 699M 4.71B 1.84B 23.73B 1.86B 1.82B 78.86B P/E 2027 *
13.7x
P/E 2028 * 10.8x
Enterprise Value 53.3B 557M 481M 452M 411M 774M 786M 5.3B 2.07B 26.69B 2.09B 2.05B 88.7B EV / Sales 2027 *
1.73x
EV / Sales 2028 * 1.42x
Free-Float
31.14%
Yield 2027 *
0.5%
Yield 2028 * 0.5%
1 day-1.63%
1 week-0.25%
Current month+0.89%
1 month+4.38%
3 months-9.70%
6 months+12.39%
Current year-9.97%
1 week 1,091
Extreme 1091
1,135
1 month 1,036.2
Extreme 1036.2
1,214
Current year 807
Extreme 807
1,400
1 year 807
Extreme 807
1,911.6
3 years 807
Extreme 807
2,406.75
5 years 387.1
Extreme 387.1
2,406.75
10 years 387.1
Extreme 387.1
2,406.75
Manager TitleAgeSince
Chief Executive Officer 41 -
Director of Finance/CFO - 2025-11-09
Compliance Officer - 2024-04-21
Director TitleAgeSince
Director/Board Member 75 2017-05-17
Director/Board Member 43 2016-10-04
Director/Board Member 41 2017-05-17
Change 5-day change 1-year change 3-year change Capi.($)
-1.63%-0.25%-41.20%+22.27% 496M
-0.52%-2.39%+2.70%+26.00% 124B
+9.79%+10.37%+383.12%+204.70% 51.43B
-0.89%-2.67%-14.14%-42.86% 39.31B
-0.10%-3.54%+15.95%-22.82% 33.9B
+0.35%-3.30%+47.39%+65.39% 24.68B
+2.18%+7.00%+19.45%-33.83% 20.6B
-3.15%+0.43%+359.15%+612.77% 19.4B
-1.75%+7.07%+32.25%+379.76% 18.9B
-0.49%-13.71%+53.69%+223.58% 18.01B
Average +0.38%+0.50%+85.84%+143.50% 35.07B
Weighted average by Cap. +1.00%+0.39%+85.88%+100.69%

Financials

2027 *2028 *
Net sales 30.88B 323M 279M 262M 238M 448M 455M 3.07B 1.2B 15.46B 1.21B 1.19B 51.38B 37.28B 390M 337M 316M 288M 541M 550M 3.71B 1.45B 18.67B 1.46B 1.43B 62.03B
Net income 3.47B 36.24M 31.3M 29.41M 26.75M 50.29M 51.12M 345M 135M 1.74B 136M 133M 5.77B 4.4B 45.98M 39.72M 37.32M 33.94M 63.81M 64.86M 437M 171M 2.2B 173M 169M 7.32B
Net Debt 5.92B 61.87M 53.44M 50.22M 45.67M 85.86M 87.28M 588M 230M 2.96B 232M 227M 9.85B 5.49B 57.4M 49.57M 46.58M 42.37M 79.65M 80.97M 546M 213M 2.75B 215M 211M 9.13B
Logo Epigral Limited
Epigral Limited is an India-based manufacturer of essential chemicals. The Company is engaged in the manufacturing and selling of chemicals, including derivatives and specialty chemicals. It operates under two businesses, Chlor-Alkali and Derivatives and Speciality chemicals, which relate to the manufacturing of Chlor-Alkali & its Derivatives. Chlor-Alkali is an industrial process that offers Sodium Hypochlorite, Hydrogen Gas, Caustic Soda Lye, Caustic Soda Flakes, and Liquid Chlorine. The Company offers a diverse portfolio of products, including chlorinated polyvinyl chloride (CPVC) Resin, CPVC Compound, Chlorotoluenes Value Chain, Epichlorohydrin, Chloromethanes, Hydrogen Peroxide, Caustic Soda, Chlorine, Hydrogen, and Caustic Potash. The Company caters to a range of industries such as refineries, paper and pulp, fluoropolymers, soaps & detergents, textiles, dyes & pigment, pharmaceuticals, agrochemicals, paints and coating, refrigerant gas, electronics, water treatment, and others.
Employees
1,135
Date Price Change Volume
26-08-14 ₹1,098.40 -1.63% 88,349
26-08-13 ₹1,116.60 +1.42% 27,215
26-08-12 ₹1,101.00 -0.53% 21,285
26-08-11 ₹1,106.90 -1.75% 35,814
26-08-10 ₹1,126.60 +2.31% 54,218
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1,098.40INR
Average target price
1,728.00INR
Spread / Average Target
+57.32%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. EPIGRAL Stock